Alejandro Jr, Regieland A.
HRN: 26-35-42 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/06/2025
LEVOFLOXACIN 500MG (TAB)
01/06/2025
01/12/2025
PO
500mg
OD
Ascites; Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalUnspecified SepsisMultiple Infections (tick All Sites) Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes